Effect of the overexpression of mutant ubiquitin (K48R) on the cellular response induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation

Neuroscience Letters

Volumn 477, Issue 3, 2010, Pages 115-120

  Hyun, Dong Hoon ^a  

^a Ewha Womans University   (South Korea)

Author keywords

4 Hydroxy 2,3 trans nonenal; Oxidative nitrative damage; Proteasome; Ubiquitin

Indexed keywords

4 HYDROXYNONENAL; CARBONYL DERIVATIVE; GLUTATHIONE; MUTANT PROTEIN; NITRIC OXIDE; POLYUBIQUITIN; UBIQUITIN;

ARTICLE; CELL METABOLISM; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NEUROPATHOLOGY; NITRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; UBIQUITINATION; WILD TYPE;

ALDEHYDES; CELL LINE, TUMOR; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MUTATION; NITRIC OXIDE; OXIDATIVE STRESS; POLYUBIQUITIN; PROTEIN CARBONYLATION; UBIQUITIN;

EID: 77953360231     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.045     Document Type: Article

References (42)

1. Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 1997, 69:1326-1329.
2. Bennett E.J., Shaler T.A., Woodman B., Ryu K.Y., Zaitseva T.S., Becker C.H., Bates G.P., Schulman H., Kopito R.R. Global changes to the ubiquitin system in Huntington's disease. Nature 2007, 448:704-708.
3. Burns M.P., Zhang L., Rebeck G.W., Querfurth H.W., Moussa C.E. Parkin promotes intracellular Abeta1-42 clearance. Hum. Mol. Genet. 2009, 18:3206-3216.
4. Castellani R.J., Harris P.L., Sayre L.M., Fujii J., Taniguchi N., Vitek M.P., Founds H., Atwood C.S., Perry G., Smith M.A. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic. Biol. Med. 2001, 31:175-180.
5. Davies J.E., Sarkar S., Rubinsztein D.C. The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias. BMC Biochem. 2007, 8(Suppl. 1):S2.
6. Friguet B., Szweda L.I. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 1997, 405:21-25.
7. Gai W.P., Blessing W.W., Blumbergs P.C. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 1995, 118(Pt 6):1447-1459.
8. Gal J., Strom A.L., Kilty R., Zhang F., Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J. Biol. Chem. 2007, 282:11068-11077.
9. Ghanevati M., Miller C.A. Phospho-beta-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction. J. Mol. Neurosci. 2005, 25:79-94.
10. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 1998, 57:338-342.
11. Grune T., Blasig I.E., Sitte N., Roloff B., Haseloff R., Davies K.J. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J. Biol. Chem. 1998, 273:10857-10862.
12. Grune T., Reinheckel T., Davies K.J. Degradation of oxidized proteins in mammalian cells. FASEB J. 1997, 11:526-534.
13. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
14. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, Oxford/New York, xxxvi, 851 p., [858] p. of plates.
15. Halliwell B., Jenner P. Impaired clearance of oxidised proteins in neurodegenerative diseases. Lancet 1998, 351:1510.
16. Hart D.A., Reno C., Hellio Le Graverand M.P., Hoffman L., Kulyk W. Expression of heat shock protein 47(Hsp47) mRNA levels in rabbit connective tissues during the response to injury and in pregnancy. Biochem. Cell Biol. 2000, 78:511-518.
17. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
18. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
19. Hyun D.H., Gray D.A., Halliwell B., Jenner P. Interference with ubiquitination causes oxidative damage and increased protein nitration: implications for neurodegenerative diseases. J. Neurochem. 2004, 90:422-430.
20. Hyun D.H., Lee M., Halliwell B., Jenner P. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults. J. Neurosci. Res. 2005, 82:232-244.
21. Hyun D.H., Lee M.H., Halliwell B., Jenner P. Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration?. J. Neurochem. 2002, 83:360-370.
22. Hyun D.H., Lee M., Halliwell B., Jenner P. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 2003, 86:363-373.
23. Lee M., Hyun D., Jenner P., Halliwell B. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J. Neurochem. 2001, 76:957-965.
24. Lee M.H., Hyun D.H., Jenner P., Halliwell B. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 2001, 78:32-41.
25. Lopez Salon M., Morelli L., Castano E.M., Soto E.F., Pasquini J.M. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 2000, 62:302-310.
26. Mayer R.J., Lowe J., Landon M., McDermott H., Laszlo L. The role of protein ubiquitination in neurodegenerative disease. Acta Biol. Hung. 1991, 42:21-26.
27. McNaught K.S., Lee M., Hyun D.H., Jenner P. Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease. Adv. Neurol. 2001, 86:73-82.
28. McNaught K.S., Olanow C.W., Halliwell B., Isacson O., Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2001, 2:589-594.
29. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 1999, 19:1959-1964.
30. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 1999, 274:23787-23793.
31. Rideout H.J., Larsen K.E., Sulzer D., Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 2001, 78:899-908.
32. Sayre L.M., Perry G., Harris P.L., Liu Y., Schubert K.A., Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 2000, 74:270-279.
33. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 1997, 17:2653-2657.
34. Smith M.A., Rudnicka-Nawrot M., Richey P.L., Praprotnik D., Mulvihill P., Miller C.A., Sayre L.M., Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 1995, 64:2660-2666.
35. Souza J.M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., Obin M., Ara J., Horwitz J., Ischiropoulos H. Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys. 2000, 380:360-366.
36. Souza J.M., Giasson B.I., Lee V.M., Ischiropoulos H. Chaperone-like activity of synucleins. FEBS Lett. 2000, 474:116-119.
37. Takanashi M., Mochizuki H., Yokomizo K., Hattori N., Mori H., Yamamura Y., Mizuno Y. Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP). Parkinsonism Relat. Disord. 2001, 7:311-314.
38. Tan Z., Sun X., Hou F.S., Oh H.W., Hilgenberg L.G., Hol E.M., van Leeuwen F.W., Smith M.A., O'Dowd D.K., Schreiber S.S. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 2007, 14:1721-1732.
39. Trotter E.W., Berenfeld L., Krause S.A., Petsko G.A., Gray J.V. Protein misfolding and temperature up-shift cause G1 arrest via a common mechanism dependent on heat shock factor in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7313-7318.
40. Tsirigotis M., Zhang M., Chiu R.K., Wouters B.G., Gray D.A. Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents. J. Biol. Chem. 2001, 276:46073-46078.
41. Turner C.P., Panter S.S., Sharp F.R. Anti-oxidants prevent focal rat brain injury as assessed by induction of heat shock proteins (HSP70, HO-1/HSP32, HSP47) following subarachnoid injections of lysed blood. Brain Res. Mol. Brain Res. 1999, 65:87-102.
42. Voges D., Zwickl P., Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 1999, 68:1015-1068.